Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 69-76, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (30)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keevil, B. G.
Right arrow Articles by Morris, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keevil, B. G.
Right arrow Articles by Morris, M. R.
Related Collections
Right arrow Drug Monitoring and Toxicology
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2002;48:69-76.)
© 2002 American Association for Clinical Chemistry, Inc.

Rapid Liquid Chromatography-Tandem Mass Spectrometry Method for Routine Analysis of Cyclosporin A Over an Extended Concentration Range

Brian G. Keevil1a, David P. Tierney1, Donald P. Cooper2 and Michael R. Morris2

1 Department of Clinical Biochemistry, Wythenshawe Hospital, Manchester M23 9LT, United Kingdom.

2 Clinical Applications Group, Micromass, UK Ltd, Manchester M23 9LZ, United Kingdom.

aAuthor for correspondence. Fax 44-161-291-2125; e-mail bkeevil{at}smuht.nwest.nhs.uk.

Background: Cyclosporin A (CsA) is commonly measured by immunoassay techniques that have a limited analytical range. The consequence of this is that low CsA concentrations that may be clinically significant are difficult to measure and that high concentrations require sample dilution, which introduces error and increases cost. More specific assays, such as HPLC, do not have the required turnaround times for busy transplant clinics.

Methods: CsA was measured in whole blood from 180 cardiac and lung transplant recipients by a liquid chromatography-tandem mass spectrometry (MS) assay, and the results were compared with the Dade Behring Emit assay. Proteins were precipitated with acetonitrile containing ascomycin as internal standard. We used isocratic elution on a Supelco CN column (33 x 3.0 mm; 3- µm bead size) with a mobile phase of 65% aqueous acetonitrile containing ammonium acetate (2 mmol/L) and formic acid (1 g/L), at a flow rate of 0.5 mL/min, with a sample injection volume of 6 µL. We used positive-ion electrospray MS to monitor the ammonium adducts of the compounds of interest decomposing under controlled conditions to the most dominant fragments of the individual molecules. Calibration curves used linear least-squares regression with 1/x weighting.

Results: Maximum sensitivity was obtained by monitoring fragmentation of the ammonium adducts m/z 1220->m/z 1203 for CsA and m/z 809->m/z 765 for ascomycin. Sample throughput, including preparation time, was 30 samples in 1.5 h with an injection-to-injection cycle time of 1.5 min. The calibration curve was linear to 5000 µg/L, with a detection limit of 0.03 µg/L and a limit of quantification of 1 µg/L. Regression analysis [tandem MS method (y) and Emit assay (x)] yielded a slope of 1.09 (± 0.03), an intercept of 6.2 (± 4.5) µg/L, and Sy|x = 27 µg/L.

Conclusions: Tandem MS assay is a realistic alternative to immunoassay for the routine monitoring of CsA in transplant recipients. Its wide dynamic range has utility for pharmacokinetic studies of CsA.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
J. Kuhn, C. Prante, S. Schon, C. Gotting, and K. Kleesiek
Measurement of Fibrosis Marker Xylosyltransferase I Activity by HPLC Electrospray Ionization Tandem Mass Spectrometry
Clin. Chem., December 1, 2006; 52(12): 2243 - 2249.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. J. Taylor, S. R. Brown, D. P. Cooper, P. Salm, M. R. Morris, P. I. Pillans, and S. V. Lynch
Evaluation of 3 Internal Standards for the Measurement of Cyclosporin by HPLC-Mass Spectrometry
Clin. Chem., October 1, 2005; 51(10): 1890 - 1893.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
R. G Morris
Immunosuppressant Drug Monitoring: Is the Laboratory Meeting Clinical Expectations?
Ann. Pharmacother., January 1, 2005; 39(1): 119 - 127.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. M. Annesley and L. Clayton
Simple Extraction Protocol for Analysis of Immunosuppressant Drugs in Whole Blood
Clin. Chem., October 1, 2004; 50(10): 1845 - 1848.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Groschl, M. Uhr, and T. Kraus
Evaluation of the Comparability of Commercial Ghrelin Assays
Clin. Chem., February 1, 2004; 50(2): 457 - 458.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.